The global Neurovascular Devices market size was valued at US$ 201 million in 2024 and is forecast to a readjusted size of USD 289 million by 2031 with a CAGR of 5.4% during review period.
Neurovascular Devices refer to the tools that used to pass through the blood vessels to diagnose and treat diseases and conditions of the brain and nervous system rather than using open surgery. Neurovascular Devices comprise a large segment of medical devices, including embolic coils, neurovascular stents (carotid and intracranial stents), intravascular devices, neurothrombectomy devices, flow diverters, embolic protection device, balloons and stent retrievers.
Top players in the neurovascular devices market are Stryker Corporation and Medtronic, Johnson & Johnson, Terumo Corporation, Penumbra, Abbott Laboratories, W. L. Gore & Associates, Microport Scientific Corporation and some others are also key players in this field.
Geographically, the neurovascular devices market is classified into North America, Europe, Japan, China and The Rest. North America dominates the global market, followed by Europe and Japan.
On the basis of product, the neurovascular devices market is classified into four major segments鈥攁neurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems, support devices, and neurothrombectomy devices. The aneurysm coiling and embolization devices segment is the largest and accounts for about 37% of the global neurovascular devices market.
Neurovascular devices are widely used in hospitals, clinics and ambulatory surgical units.
This report is a detailed and comprehensive analysis for global Neurovascular Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Neurovascular Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Neurovascular Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Neurovascular Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Neurovascular Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neurovascular Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neurovascular Devices market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Stryker Corporation, Johnson & Johnson, Medtronic, Terumo, Penumbra, Microport Scientific Corporation, Abbott Vascular, W. L. Gore & Associates, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Neurovascular Devices market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Aneurysm Coiling & Embolization Devices
Cerebral Balloon Angioplasty & Stenting Systems
Support Devices
Neurothrombectomy Devices
麻豆原创 segment by Application
Hospitals
Clinics
Ambulatory Surgical Units
Major players covered
Stryker Corporation
Johnson & Johnson
Medtronic
Terumo
Penumbra
Microport Scientific Corporation
Abbott Vascular
W. L. Gore & Associates
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neurovascular Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Neurovascular Devices, with price, sales quantity, revenue, and global market share of Neurovascular Devices from 2020 to 2025.
Chapter 3, the Neurovascular Devices competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neurovascular Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Neurovascular Devices market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Neurovascular Devices.
Chapter 14 and 15, to describe Neurovascular Devices sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Neurovascular Devices Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Aneurysm Coiling & Embolization Devices
1.3.3 Cerebral Balloon Angioplasty & Stenting Systems
1.3.4 Support Devices
1.3.5 Neurothrombectomy Devices
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Neurovascular Devices Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Ambulatory Surgical Units
1.5 Global Neurovascular Devices 麻豆原创 Size & Forecast
1.5.1 Global Neurovascular Devices Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Neurovascular Devices Sales Quantity (2020-2031)
1.5.3 Global Neurovascular Devices Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Stryker Corporation
2.1.1 Stryker Corporation Details
2.1.2 Stryker Corporation Major Business
2.1.3 Stryker Corporation Neurovascular Devices Product and Services
2.1.4 Stryker Corporation Neurovascular Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Stryker Corporation Recent Developments/Updates
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Neurovascular Devices Product and Services
2.2.4 Johnson & Johnson Neurovascular Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Johnson & Johnson Recent Developments/Updates
2.3 Medtronic
2.3.1 Medtronic Details
2.3.2 Medtronic Major Business
2.3.3 Medtronic Neurovascular Devices Product and Services
2.3.4 Medtronic Neurovascular Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Medtronic Recent Developments/Updates
2.4 Terumo
2.4.1 Terumo Details
2.4.2 Terumo Major Business
2.4.3 Terumo Neurovascular Devices Product and Services
2.4.4 Terumo Neurovascular Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Terumo Recent Developments/Updates
2.5 Penumbra
2.5.1 Penumbra Details
2.5.2 Penumbra Major Business
2.5.3 Penumbra Neurovascular Devices Product and Services
2.5.4 Penumbra Neurovascular Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Penumbra Recent Developments/Updates
2.6 Microport Scientific Corporation
2.6.1 Microport Scientific Corporation Details
2.6.2 Microport Scientific Corporation Major Business
2.6.3 Microport Scientific Corporation Neurovascular Devices Product and Services
2.6.4 Microport Scientific Corporation Neurovascular Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Microport Scientific Corporation Recent Developments/Updates
2.7 Abbott Vascular
2.7.1 Abbott Vascular Details
2.7.2 Abbott Vascular Major Business
2.7.3 Abbott Vascular Neurovascular Devices Product and Services
2.7.4 Abbott Vascular Neurovascular Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Abbott Vascular Recent Developments/Updates
2.8 W. L. Gore & Associates
2.8.1 W. L. Gore & Associates Details
2.8.2 W. L. Gore & Associates Major Business
2.8.3 W. L. Gore & Associates Neurovascular Devices Product and Services
2.8.4 W. L. Gore & Associates Neurovascular Devices Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 W. L. Gore & Associates Recent Developments/Updates
3 Competitive Environment: Neurovascular Devices by Manufacturer
3.1 Global Neurovascular Devices Sales Quantity by Manufacturer (2020-2025)
3.2 Global Neurovascular Devices Revenue by Manufacturer (2020-2025)
3.3 Global Neurovascular Devices Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Neurovascular Devices by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Neurovascular Devices Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Neurovascular Devices Manufacturer 麻豆原创 Share in 2024
3.5 Neurovascular Devices 麻豆原创: Overall Company Footprint Analysis
3.5.1 Neurovascular Devices 麻豆原创: Region Footprint
3.5.2 Neurovascular Devices 麻豆原创: Company Product Type Footprint
3.5.3 Neurovascular Devices 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Neurovascular Devices 麻豆原创 Size by Region
4.1.1 Global Neurovascular Devices Sales Quantity by Region (2020-2031)
4.1.2 Global Neurovascular Devices Consumption Value by Region (2020-2031)
4.1.3 Global Neurovascular Devices Average Price by Region (2020-2031)
4.2 North America Neurovascular Devices Consumption Value (2020-2031)
4.3 Europe Neurovascular Devices Consumption Value (2020-2031)
4.4 Asia-Pacific Neurovascular Devices Consumption Value (2020-2031)
4.5 South America Neurovascular Devices Consumption Value (2020-2031)
4.6 Middle East & Africa Neurovascular Devices Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Neurovascular Devices Sales Quantity by Type (2020-2031)
5.2 Global Neurovascular Devices Consumption Value by Type (2020-2031)
5.3 Global Neurovascular Devices Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Neurovascular Devices Sales Quantity by Application (2020-2031)
6.2 Global Neurovascular Devices Consumption Value by Application (2020-2031)
6.3 Global Neurovascular Devices Average Price by Application (2020-2031)
7 North America
7.1 North America Neurovascular Devices Sales Quantity by Type (2020-2031)
7.2 North America Neurovascular Devices Sales Quantity by Application (2020-2031)
7.3 North America Neurovascular Devices 麻豆原创 Size by Country
7.3.1 North America Neurovascular Devices Sales Quantity by Country (2020-2031)
7.3.2 North America Neurovascular Devices Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Neurovascular Devices Sales Quantity by Type (2020-2031)
8.2 Europe Neurovascular Devices Sales Quantity by Application (2020-2031)
8.3 Europe Neurovascular Devices 麻豆原创 Size by Country
8.3.1 Europe Neurovascular Devices Sales Quantity by Country (2020-2031)
8.3.2 Europe Neurovascular Devices Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Neurovascular Devices Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Neurovascular Devices Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Neurovascular Devices 麻豆原创 Size by Region
9.3.1 Asia-Pacific Neurovascular Devices Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Neurovascular Devices Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Neurovascular Devices Sales Quantity by Type (2020-2031)
10.2 South America Neurovascular Devices Sales Quantity by Application (2020-2031)
10.3 South America Neurovascular Devices 麻豆原创 Size by Country
10.3.1 South America Neurovascular Devices Sales Quantity by Country (2020-2031)
10.3.2 South America Neurovascular Devices Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Neurovascular Devices Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Neurovascular Devices Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Neurovascular Devices 麻豆原创 Size by Country
11.3.1 Middle East & Africa Neurovascular Devices Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Neurovascular Devices Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Neurovascular Devices 麻豆原创 Drivers
12.2 Neurovascular Devices 麻豆原创 Restraints
12.3 Neurovascular Devices Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Neurovascular Devices and Key Manufacturers
13.2 Manufacturing Costs Percentage of Neurovascular Devices
13.3 Neurovascular Devices Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Neurovascular Devices Typical Distributors
14.3 Neurovascular Devices Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Stryker Corporation
Johnson & Johnson
Medtronic
Terumo
Penumbra
Microport Scientific Corporation
Abbott Vascular
W. L. Gore & Associates
听
听
*If Applicable.
